General Information
DRAVP ID DRAVPe00821
Peptide Name II22N17
Sequence KIEEIESKIKKIENEIARIKKLLQLTVWGIKQLQARIL
Sequence Length 38
UniProt ID No entry found
Source Synthetic construct
Activity Information
Target Organism HIV
Assay HIV luciferase assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target membrane
Mechanism The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe00821
Linear/Cyclic Linear
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C207H362N56O55
Absent amino acids CDFHMPY
Common amino acids I
Mass 4515.49
Pl 9.87
Basic residues 9
Acidic residues 5
Hydrophobic residues 17
Net charge 4
Boman Index -5708
Hydrophobicity -20.53
Aliphatic Index 146.32
Half Life
Extinction Coefficient cystines 5500
Absorbance 280nm 148.65
Polar residues 4
Literature Information
Literature 1
Title Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.
Pubmed ID 11572974
Reference Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.
Author Eckert DM, Kim PS.